Update April 21: The U.S. Supreme Court voted 7-2 to stay the rulings of lower courts that restricted mifepristone access. As a result, for now, there is no change to the FDA’s approval of mifepristone or how it can be used while the case proceeds. The national legal battle over mifepristone will continue in the […]
